Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin.
A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI).
A simple chromogenic substrate assay of tissue factor pathway inhibitor activity in plasma and serum.
Tissue factor pathway inhibitor activity in severe sepsis.
Creasey AA, Reinhart K.
Crit Care Med. 2001 Jul;29(7 Suppl):S126-9. doi: 10.1097/00003246-200107001-00038.
Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
van Paridon PCS, Panova-Noeva M, van Oerle R, Schulz A, Prochaska JH, Arnold N, Schmidtmann I, Beutel M, Pfeiffer N, Münzel T, Lackner KJ, Hackeng TM, Ten Cate H, Wild PS, Spronk HMH.
Thromb Haemost. 2021 Feb;121(2):174-181. doi: 10.1055/s-0040-1715897. Epub 2020 Sep 2.
Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.
Mast AE.
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):9-14. doi: 10.1161/ATVBAHA.115.305996. Epub 2015 Nov 24.
The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study.
Cao X, Su Y, Zhang W, Zhao H, Wen M, Lu S, Zhao Y, Chen Y, Liu L, Zang X, Wu J.
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211063877. doi: 10.1177/10760296211063877.
Tissue factor pathway inhibitor: structure-function.
Broze GJ Jr, Girard TJ.
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.
Tissue factor pathway inhibitor: then and now.
Ellery PE, Adams MJ.
Semin Thromb Hemost. 2014 Nov;40(8):881-6. doi: 10.1055/s-0034-1395153. Epub 2014 Nov 6.
Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.
Dahm A, Rosendaal FR, Andersen TO, Sandset PM.
Br J Haematol. 2006 Feb;132(3):333-8. doi: 10.1111/j.1365-2141.2005.05876.x.
Associations of tissue factor and tissue factor pathway inhibitor with organ dysfunctions in septic shock.
Lehner GF, Tobiasch AK, Perschinka F, Mayerhöfer T, Waditzer M, Haller V, Zassler B, Maier S, Ulmer H, Joannidis M.
Sci Rep. 2024 Jun 24;14(1):14468. doi: 10.1038/s41598-024-65262-3.
Tissue factor pathway.
McVey JH.
Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):361-72. doi: 10.1053/beha.1999.0030.
Tissue factor pathway inhibitor: regulation of its inhibitory activity by phospholipid surfaces.
Lindhout T, Salemink I, Valentin S, Willems GM.
Haemostasis. 1996 Oct;26 Suppl 4:89-97. doi: 10.1159/000217289.
